AMAG Pharma (AMAG) Misses Q2 EPS by 21c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Financial Fact:
Product sales, net: 115.78M
Today's EPS Names:
OMID, SICP, SCKT, More
Financial Fact:
Product sales, net: 115.78M
Today's EPS Names:
OMID, SICP, SCKT, More
Join SI Premium – FREE
AMAG Pharma (NASDAQ: AMAG) reported Q2 EPS of ($0.58), $0.21 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $146.25 million versus the consensus estimate of $155.81 million.
For earnings history and earnings-related data on AMAG Pharma (AMAG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TransUnion (TRU) Tops Q3 EPS by 4c; Offers FY26 EPS Guidance
- Rambus (RMBS) Tops Q3 EPS by 5c, Offers Guidance
- Hycroft Mining (HYMC) Misses Q3 EPS by 11c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
